Vantive: A New Company Built On Our Legacy Baxter is on a journey to separate our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapies and home and in-center dialysis to p...
Sobre a Alice Somos a Alice, a primeira gestora de saúde do Brasil. Acreditamos em um modelo de saúde inovador e colocamos o nosso membro no centro das decisões por meio da tecnologia, empatia, transparência e simplicidade. A nossa mi...
includes perform EKG, collect vital signs. This is an excellent opportunity if you have experience working as a nurse... a clinical environment or medical setting, e.g. clinical research coordinator, nurse, medical assistant, other medical profession...
Kalana Ispat IPO: The subscription for for the Kalana Ispat IPO began on September 19, 2024, and it concluded on September 23, 2024. As allotment is likely to be out soon here are the steps to check allotment status online, GMP as focus shifts to listing Continue Reading »
Shares of Popular Foundations, a company specializing in engineering and construction activities with comprehensive end-to-end solutions in the construction sector, made a muted debut on the BSE SME platform today, listing at the same price as the IPO of ₹37. Continue Reading »
Laxmi Organic Industries share price has gained over 7% in one month and more than 15% in three months. However, the mid-cap stock has remained rangedbound in one year as has gained just 5% during the period. Continue Reading »
With lower fees and efficient tracking of overall market performance, passive investing is a relatively safe choice, particularly in volatile markets, experts say Continue Reading »
Northern Arc Capital vs Arkade Developer vs Western Carriers India: Experts believe that Northern Arc Capital shares are better placed against other two shares Continue Reading »
Balu Forge Industries, part of Ashish Kacholia's portfolio, surged over 11% to a record ₹890 after announcing the acquisition of CNC Machines. Continue Reading »
Advik Capital's rights issue opened on September 24, 2024, allowing shareholders to buy new shares at ₹2.50 each until October 4. The company aims to raise ₹49.95 crore to expand operations, despite a recent stock decline of 2.3%. Continue Reading »